Bioventus
BVS
BVS
98 hedge funds and large institutions have $232M invested in Bioventus in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 23 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
48% less capital invested
Capital invested by funds: $447M → $232M (-$215M)
Holders
98
Holding in Top 10
3
Calls
$88K
Puts
–
Top Buyers
| 1 | +$7.98M | |
| 2 | +$4.22M | |
| 3 | +$3.05M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.99M |
| 5 |
BlackRock
New York
|
+$1.48M |
Top Sellers
| 1 | -$5.13M | |
| 2 | -$1.24M | |
| 3 | -$1.18M | |
| 4 |
DIA
Dean Investment Associates
Beavercreek,
Ohio
|
-$882K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$878K |